Duloxetine in Affective Disorders: a Naturalistic Study on Psychiatric and Medical Comorbidity, Use in Association and Tolerability Across Different Age Groups

OBJECTIVE: Duloxetine, a selective serotonin and norepinephrine reuptake inhibitor (SNRI), is currently approved in many countries for the treatment of Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). The present naturalistic study was aimed to investigate tolerability of Dulo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dell’Osso, Bernardo, Camuri, Giulia, Dobrea, Cristina, Buoli, Massimiliano, Serati, Marta, Carlo Altamura, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496903/
https://www.ncbi.nlm.nih.gov/pubmed/23166563
http://dx.doi.org/10.2174/1745017901208010120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496903/
https://www.ncbi.nlm.nih.gov/pubmed/23166563
http://dx.doi.org/10.2174/1745017901208010120

Ejemplares similares